Key Points. To analyze the rates and reasons for trial ineligibility by race and ethnicity in multiple myeloma (MM) clinical trials.
— Read on ashpublications.org/blood/article/doi/10.1182/blood.2022018657/495571/Eligibility-criteria-and-Enrollment-of-a-Diverse